✦ LIBER ✦

First-in-human trial of Dz13 for nodular basal-cell carcinoma

✍ Scribed by Grassi, Gabriele; Grassi, Mario

Book ID: 123008531
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 152 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)60633-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dz13 proves safe and well tolerated in t

Dz13 proves safe and well tolerated in the first human trial

✍ Joanny, J. -F.; Kruse, K.; Prost, J.; Ramaswamy, S. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

Imiquimod Treatment of Superficial and N

Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label Trial

✍ Ketty Peris; Elena Campione; Tamara Micantonio; Georgiana Clare Marulli; Maria C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Efficacy of Topical 5% Imiquimod Cream f

Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell Carcinoma

✍ Shumack, Stephen 📂 Article 📅 2002 🏛 American Medical Association 🌐 English ⚖ 160 KB

Detection of human papilloma virus in no

Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects

✍ B. Escutia; E. Ledesma; C. Serra-Guillen; C. Gimeno; J.J. Vilata; C. Guillén; E. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Terahertz Pulsed Spectroscopy of Human B

Terahertz Pulsed Spectroscopy of Human Basal Cell Carcinoma

✍ Wallace, Vincent P.; Fitzgerald, Anthony J.; Pickwell, Emma; Pye, Richard J.; Ta 📂 Article 📅 2006 🏛 Society for Applied Spectroscopy 🌐 English ⚖ 346 KB

Combination of Er:YAG laser and photodyn

Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma

✍ Roman Šmucler; Marek Vlk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract ## Backgrounds and Objectives Photodynamic therapy (PDT), via topical aminolevulinic acid (ALA) is an effective treatment for basal cell carcinomas not exceeding a depth of 2 mm. This limits the treatment of basal cell carcinoma (non‐melanoma skin cancer) to superficial forms and nodul